4487.jpg?itok=LooO274g)
Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Disease Learning
NEWLY DIAGNOSED
VIDEO LIBRARIES
En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el...
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their...
The Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón presentado el 9 de agosto de 2025 has now ended. ¡Los vídeos están disponibles BAJO...
In these videos, Dr. Jared Weiss provides a brief overview of the HPV vaccination and its role in head and neck cancer, examines cetuximab as the...
In this Program, Drs. Arya Mariam Roy, Assistant Professor at The Ohio State University, Erick Saldanha, Medical Oncologist & Postdoctoral Clinical...
ARTICLES
Get Ready to Explore the Refreshed Global Resource for Advancing Cancer Education Website! Look at our new look! View a quick video walkthrough below...
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
As part of the 2025 Blood Cancer Video Library, where oncologists discuss the most emerging treatment options and information in blood cancer, Dr. Shaji Kumar (Mayo Clinic) discusses optimal strategies for the treatment of newly diagnosed multiple myeloma (MM).
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
COMMUNITY FORUM
Hello, I was diagnosed with stage three sarcoma (MFH) in my left thigh. I underwent five weeks of radiation followed by a resection, and all the...
Get Ready to Explore the Refreshed Global Resource for Advancing Cancer Education Website! Look at our new look! View a quick video walkthrough below...
En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el...
Sharing experiences is vital to our learning. Getting a perspective from someone who has been there is often more valuable than getting info through...
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.